Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMIRE: Does the Addition of Mitoxantrone Improve Response
2008-006342-25Phase 4Unknown
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Nov 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mitoxantrone in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Complete Response rate. Status: unknown.
02
Drugs
mitoxantrone
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2008-006342-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006342-25.